![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
July 10, 2025
A call to champion federally-funded cancer research, a discussion on limited radiation exposure from CT scans, and a TAILORx trial update
June 11, 2025
Grant updates; engineering and cancer research; Spring Group Meeting and ASCO highlights
April 24, 2025
An update on the Group's activity; a new Central Biorepository and Pathology Facility director; a preview of key Group Meeting sessions
March 21, 2025
An update on the NCTN Grant; upcoming Group Meeting highlights; a perspective on the mistrust of science
February 19, 2025
The co-chairs highlight the immense value of Cooperative Group cancer research and the importance of its continued funding
December 23, 2024
The co-chairs reflect on the past year in cancer research and make the case for embracing the inclusion of real-world data in ECOG-ACRIN
November 25, 2024
Fall Group Meeting highlights; impactful results in head and neck cancer; a ComboMATCH update
October 17, 2024
The co-chairs reflect on how the cancer research landscape has evolved over the last five years
September 17, 2024
Fall Comis Symposium to focus on inflammation as a cause of cancer; ECOG-ACRIN readies for NCTN Grant resubmission
August 14, 2024
Thoughts on the evolving clinical cancer research environment—and practice-changing results in acute lymphoblastic leukemia
July 3, 2024
GI Cancer Committee displays strong representation at ASCO; real-world data study nears activation; ECOG-ACRIN commends NCI's appointment of senior advisor for clinical research
June 11, 2024
A Spring Group Meeting recap; a milestone for TMIST; a new myeloMATCH treatment trial